High Reintervention and Amputation Rates After Outpatient Atherectomy for Claudication

Vascular and Endovascular Surgery

Volumn 52, Issue 6, 2018, Pages 427-433

  Mukherjee, Dipankar ^a   Contos, Brian ^b   Emery, Erica ^a   Collins, Devon T ^a,c   Black, James H ^d  

^a Inova Fairfax Medical Campus ^*  (United States)

^b Advisory Board Company   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

amputation; atherectomy; claudication; endovascular therapy; Medicare; peripheral artery disease (PAD); reimbursement

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AMPUTATION; ARTICLE; ATHERECTOMY; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLAUDICATION; CONTROLLED STUDY; FEMALE; FEMORAL POPLITEAL ATHERECTOMY; FEMUR; HUMAN; HYPERTENSION; LOWER LIMB; MALE; OUTPATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REIMBURSEMENT; TIBIAL PERONEAL ATHERECTOMY; AGED; AMBULATORY SURGERY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; FACTUAL DATABASE; INTERMITTENT CLAUDICATION; LIMB SALVAGE; MEDICARE; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY SURGICAL PROCEDURES; AMPUTATION; ATHERECTOMY; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; LIMB SALVAGE; LOWER EXTREMITY; MALE; MEDICARE PART B; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85046774129     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574418772459     Document Type: Article

References (33)

1. Belch JJ, Topol EJ, Agnelli G. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163(8):884–892
2. Hirsch AT, Haskal ZJ, Hertzer NR. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–e654
3. Mahoney EM, Wang K, Cohen DJ. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008;1(1):38–45
4. Fowkes FGR, Rudan D, Rudan I. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340
5. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50(1):54–60
6. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. 2009;49(4):910–917
7. Jones WS, Mi X, Qualls LG. Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. J Am Coll Cardiol. 2015;65(9):920–927
8. Mukherjee D, Hashemi H, Contos B. The disproportionate growth of office-based atherectomy. J Vasc Surg. 2017;65(2):495–500
9. Department of Health and Human Services. Medicare program; Payment policies under the physician fee schedule and other revisions to Part B for CY 2011; Final Rule. Federal Register. 2010;75:228. https://www.gpo.gov/fdsys/pkg/FR-2010-11-29/pdf/2010-27969.pdf
10. Jones DW, Schanzer A, Zhao Y. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc. 2013;2(6):e000345
11. Office for Human Research Protections (OHRP), United States Department of Health and Human Services. Title 45 Public Welfare Part 48 Protection of Human Subjects. Code of Federal Regulations. July 14, 2009. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#46.102. Accessed March 15, 2018
12. R version 3.2.3. R Core Team. Vienna, Austria. https://www.r-project.orgInc; 2017
13. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2):384–392
14. Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51(3):395–403
15. Murphy TP, Cutlip DE, Regensteiner JG. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999–1009
16. Murphy TP, Cutlip DE, Regensteiner JG. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130–139
17. McDermott MM, Guralnik JM, Criqui MH. Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc. 2014;3(3):e000711
18. Collins TC, Lunos S, Carlson T. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care. 2011;34(10):2174–2179
19. Aquino R, Johnnides C, Makaroun M. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg. 2001;34(6):962–970
20. Muluk SC, Muluk VS, Kelley ME. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg. 2001;33(2):251–257-258
21. Weitz JI, Byrne J, Clagett GP. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94(11):3026–3049
22. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 1999;12(2):123–137
23. Mazari FAK, Khan JA, Samuel N. Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease. Br J Surg. 2017;104(1):76–83
24. Gohil RA, Mockford KA, Mazari FA. Percutaneous transluminal angioplasty results in improved physical function but not balance in patients with intermittent claudication. J Vasc Surg. 2013;58(6):1533–1539
25. Gohil RA, Mockford KA, Mazari F. Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication. Ann Vasc Surg. 2013;27(1):68–74
26. Giugliano G, Di Serafino L, Perrino C. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. Int J Cardiol. 2013;167(6):2566–2571
27. Taylor SM, Kalbaugh CA, Healy MG. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? A single center experience of 1,000 consecutively treated limbs. J Am Coll Surg. 2008;206(5):1053–1062
28. Bradbury AW, Adam DJ, Bell J. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(suppl 5):5S–17S
29. Ambler GK, Radwan R, Hayes PD, Twine CP. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev. 2014;(3):CD006680
30. Krishnan P, Tarricone A, Purushothaman R. An algorithm for the use of embolic protection during atherectomy for femoral popliteal lesions. JACC Cardiovasc Interv. 2017 2 27;10(4):403–410
31. Muller-Hulsbeck S, Humme TH, Philipp-Schafer J. Final results of the protected superficial femoral artery trial using the FilterWire EZ system. Cardiovasc Intervent Radiol. 2010;33(6):1120–1127
32. Gray BH, Diaz-Sandoval LJ, Dieter RS, Jaff MR, White CJ. SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014;84(4):539–545
33. Klein AJ, Pinto DS, Gray BH, Jaff MR, White CJ, Drachman DE. SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014;84(4):529–538